Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 10, 2021

SELL
$56.61 - $80.46 $140,279 - $199,379
-2,478 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$86.23 - $125.19 $213,677 - $310,220
2,478 New
2,478 $231,000
Q2 2019

Aug 12, 2019

SELL
$39.92 - $53.86 $4,710 - $6,355
-118 Closed
0 $0
Q4 2018

May 21, 2019

BUY
$55.63 - $73.24 $6,564 - $8,642
118 New
118 $7,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $438M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Cresset Asset Management, LLC Portfolio

Follow Cresset Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.